SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-20-000053
Filing Date
2020-04-29
Accepted
2020-04-29 16:50:59
Documents
2
Period of Report
2020-04-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20208-k29april2020.htm 8-K 38517
2 EXHIBIT 3.1 exhibit29april2020.htm EX-3.1 96145
  Complete submission text file 0000920465-20-000053.txt   135809
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 20831155
SIC: 2836 Biological Products, (No Diagnostic Substances)